Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Cell-Derived Influenza Vaccine in Adults
NCT00889889Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- May 2009
- Primary completion
- Jan 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of cell-based trivalent influenza virus vaccine in influenza, sponsored by Abbott Laboratories. Started May 2009; status: completed.
02
Drugs
cell-based trivalent influenza virus vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00889889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00889889.